SUMMARY To provide an objective rapid means of excluding extrahepatic biliary atresia (atresia), a hepatic index was devised from the ratio of the net hepatic to cardiac distribution of 99mTc diisopropyl iminodiacetic acid or methylbrom iminodiacetic acid between 2-5 and 10 minutes after injection. The hepatic index was compared with subjective assessment of abdominal scintigraphy performed repeatedly over 24 hours. In 22 infants with hepatitis the hepatic index ranged from 5*03 to 14-9, one having no excretion on scintiscan. In 26 infants with atresia the index ranged from 0-49 to 4-26 and in two with paucity of intralobular bile ducts it was 1-85 and 3-69. None of these infants had excretion apparent on scintiscans. Similarly, low hepatic indices occurred in four infants with liver dysfunction but pigmented stools, three of whom had no excretion apparent on scintiscans. These preliminary studies suggest that a hepatic index of greater than 5 is much more rapid and as specific in excluding atresia as repeated abdominal scintigraphy.
SUMMARY To provide an objective rapid means of excluding extrahepatic biliary atresia (atresia), a hepatic index was devised from the ratio of the net hepatic to cardiac distribution of 99mTc diisopropyl iminodiacetic acid or methylbrom iminodiacetic acid between 2-5 and 10 minutes after injection. The hepatic index was compared with subjective assessment of abdominal scintigraphy performed repeatedly over 24 hours. In 22 infants with hepatitis the hepatic index ranged from 5*03 to 14-9, one having no excretion on scintiscan. In 26 infants with atresia the index ranged from 0-49 to 4-26 and in two with paucity of intralobular bile ducts it was 1-85 and 3-69. None of these infants had excretion apparent on scintiscans. Similarly, low hepatic indices occurred in four infants with liver dysfunction but pigmented stools, three of whom had no excretion apparent on scintiscans. These preliminary studies suggest that a hepatic index of greater than 5 is much more rapid and as specific in excluding atresia as repeated abdominal scintigraphy. To investigate the specificity of our findings and clarify mechanisms responsible the investigation was performed in four further infants who had bile pigmented stools and thus were not suspected of having atresia. Two had idiopathic fulminant hepatic failure, one was recovering from portal pyaemia, and one had liver disease associated with panhypopituitarism. Informed consent was obtained from the parents.
Methods
Development of the hepatic index. After at least three days of oral phenobarbitone in a dose of 5 mg/kg/day8 37 mBq of 99mTc DISIDA (Disofen, New England Nuclear Chemicals Ltd) was given intravenously. The infant was placed for 10 mninutes over an International General Electric (535) gammacamera linked to an Analog Data Analysis Company computer system. Gamma emissions were recorded continuously in 30 second frames.
One 30 second recording was subsequently displayed on a television monitor and, using the computer linked pen, areas were defined within the outline of the liver, heart, and lung fields (representing background activity) (Fig. 1) . The counts in these areas were analysed in all 30 second frames, corrected to unit area, and depicted as an activity/-time curve, giving the count density over the liver, heart, and background as a function of time. Analysis of these curves in 19 infants, 11 of whom had atresia, showed that complete separation of patients with atresia from those with intrahepatic disease could be obtained from frames between 2 5 and 10 minutes after injection on the basis of the ratio of the net counts over the liver and heart. This ratio, counts over liver minus counts over background divided by counts over heart minus counts over background during this 7 5 minute period, we termed the hepatic index.
Prospective study. The hepatic index was applied prospectively in 35 infants. In these studies the derivative of iminodiacetic acid 99mtechnetium trimethylbrom-IDA (TMB-IDA) (Sorin Biomedica SPA) was used as DISIDA was withdrawn temporarily from use in the United Kingdom. TMB-IDA Two infants with fulminant hepatic failure and one with panhypopituitarism also had low hepatic indices (1-85, 3-69, and 1-34, respectively). No bowel radioactivity could be detected in these infants and all had markedly reduced hepatic uptake. The infant recovering from portal pyaemia also had a low hepatic index of 2-3 but bowel radioactivity was evident at seven hours. This infant, too, had markedly reduced hepatic uptake. The comparison of the hepatic index and hepatic uptake (Fig. 2) showed that when the index was greater than 5 there was a high uptake of the radiopharmaceutical, whereas when the index was less than Hepatic index Fig. 2 The relation between hepatic index and hepatic uptake (the ratio ofnet hepatic counts to background counts) in 30 infants. O=Biliary atresia; O=idiopathic hepatitis of infancy; * =hepatitis with a, antitrypsin deficiency; -=portal pyaemia; A -fulminant hepatic failure; A =paucity of intrahepatic bile ducts. the uptake was reduced. There was no significant relation beween the hepatic index and net cardiac counts. DISIDA and TMB-IDA are rapidly taken up by the liver and have low but appreciable renal excretion in infants with cholestasis. 99mTechnetium has good imaging properties but its short half life of six hours makes assessment of scintiscans difficult after 12 hours. Other authors have evaluated clearance from the blood and hepatic uptake in an effort to overcome problems caused by renal excretion of the radiopharmaceutical and short half life of 99mtechnetium.
Discussion
Gerhold and coworkers, in a study of 16 infants with atresia and 11 with hepatitis using DISIDA and diethyl IDA, used an entirely subjective method of grading clearance from the blood. 4 Patients with no visible cardiac radioactivity after five minutes had a numerical score of 1, while if there was considerable retention in the circulation, with the cardiac activity equalling or exceeding the hepatic activity by five minutes, a score of 4 was given. These authors found that patients with atresia had low scores and those with hepatitis higher scores but that there was considerable overlap between the two groups.
Kirk and coworkers, in a study of 15 infants with cholestasis using DISIDA, analysed 12 images taken in the first hour and five taken in the subsequent 23 hours.'5 They found that in infants with hepatitis and severe hepatocellular damage uptake into the liver was delayed, while in infants with atresia the uptake was normal. Again the assessment was subjective.
Bourdelat and coworkers, in a study of eight infants, three of whom had atresia, used diethyl IDA scintographic images to generate time/activity curves.'6 They also concluded that a good hepatic uptake was suggestive of atresia. The single time/ activity curve given, however, showed that in the early stages the opposite was true. Lennard et al, using diethyl IDA, subjectively analysed time/ activity curves obtained over 60 minutes in six infants with atresia and 11 with hepatitis and found no appreciable hepatic uptake in patients with hepatitis but good hepatic uptake in patients with atresia.
In our studies using both DISIDA and TMB-IDA we found the opposite. In those patients with a cholestatic syndrome that was clinically indistinguishable from atresia the hepatic index was more satisfactory in those with hepatitis than in those with atresia. This may be due to differences in the patient population studied, treatment with phenobarbitone beforehand, or the hepatic extraction of the radiopharmaceuticals used. They are more likely to have arisen, however, because our study concentrated on the very early hepatic uptake and was entirely objective.
The cause of the slow hepatic uptake in patients with atresia is unclear. The clinical and pathological features in infants with hepatocellular damage associated with a, antitrypsin deficiency are often indistinguishable from infants with atresia, but the hepatic index in the patients with a, antitrypsin deficiency was similar to that in other types of intrahepatic disease. The low hepatic indices found in the patients with fulminant hepatic failure with a prothrombin time prolonged by more than 40 seconds at the time of the study was not surprising in that severe hepatocellular failure was present. The low hepatic index found in the patient during the recovery phase was from portal pyaemia and the infant with panhypopituitarism is unexplained. Knodell 
